| Literature DB >> 21928099 |
Caren Carlaw1, Heather Finlayson, Kathleen Beggs, Tiffany Visser, Caroline Marcoux, Dawn Coney, Catriona M Steele.
Abstract
There is considerable clinical interest in the risks and benefits of offering oral water intake, in the form of water protocols, to patients with thin-liquid dysphagia. We describe the design and implementation of a water protocol for patients in a rehabilitation setting with videofluoroscopically confirmed thin-liquid aspiration. The GF Strong Water Protocol (GFSWP) is an interdisciplinary initiative, with roles and accountabilities specified for different members of the interprofessional health-care team. Rules of the water protocol specify mode of water access (independent, supervised), the implementation of any safe swallowing strategies recommended on the basis of the patient's videofluoroscopy, and procedures for evaluating and addressing oral care needs. Trial implementation of the water protocol in 15 participants showed that they remained free of adverse events, including pneumonia, over the course of an initial 14-day trial and continuing until discharge from the facility (range = 13-108 days). Seven participants were randomly assigned to a 14-day control phase in which they received standard care (without water access). Fluid intake measures taken after the oral water intake phase were increased (mean = 1,845 cc; 95% confidence interval: 1,520-2,169 cc) compared to those in the control phase (mean = 1,474 cc; 95% CI: 1,113-1,836 cc), with oral water intake measures comprising, on average, 563 cc (range = 238-888 cc) of the total post water trial fluid intake values. Fluid intake increased at least 10% of the calculated fluid requirements in 11/15 participants who received oral water access. These participants reported favorable quality-of-life outcomes, measured using the Swal-QOL. These findings support the implementation of the GFSWP, including its exclusion criteria, rules, and plans of care, for rehabilitation patients who aspirate thin liquids.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21928099 PMCID: PMC3417096 DOI: 10.1007/s00455-011-9366-9
Source DB: PubMed Journal: Dysphagia ISSN: 0179-051X Impact factor: 3.438
Issues identified during the preparation phase for GFSWP implementation
| Issue | Response |
|---|---|
| Eligibility | Exclusion criteria to determine those patients for whom a water protocol would be contraindicated |
| Oral health | (a) Procedures for evaluating and documenting oral health status in patients being considered for a water protocol (b) Procedures to determine whether suction equipment is needed during oral care activities for patients who will be on the water protocol |
| Medical approval | A physician’s order will be obtained for the water protocol for all selected patients, so that medical contraindications are considered and so that the provision of water is considered of equal importance to the administration of medications |
| Supervision/assistance | Team assessment to determine whether a patient is able to follow the rules and complete all the steps of the water protocol, including oral care, independently, or whether supervision/assistance is needed |
| Rules for water provision | Water will be delivered by a nurse in a new, labeled, graduated bottle each morning. Water will be poured from this bottle into a cup for drinking. New bottles of water will be stored at the nursing station. Water bottles will be replaced when empty, not refilled |
| Procedures for recording water intake | The water remaining in the previous bottle will be recorded on a water intake sheet, noting the bottle label number, upon delivery of a new bottle |
| Access | Patients who are determined to need assistance will be explicitly offered water by clinical staff throughout the day, between meals |
| Accountabilities | Policies to identify the roles, responsibilities, accountabilities, and documentation requirements of different members of the interdisciplinary health-care team in supporting implementation of the water protocol |
Fig. 1Water protocol algorithm
Rules of the GFSWP
| Consideration | Instructions |
|---|---|
| Oral care | To be done first thing in the morning, prior to oral intake, and at bedtime Swab mouth or rinse-and-spit to be performed prior to any water intake |
| Oral water intake | Water from a cup permitted between meals, after oral care Any strategies or precautions recommended based on videofluoroscopy to be used |
| Meal-time fluids | Prescribed thickened liquid (i.e., nectar- or honey-thick liquid) to be used Oral water intake not permitted during meals or for 30 min afterwards |
| Medications | All pills to be taken with the prescribed thickened liquid or puree |
Means (and 95% confidence intervals) for 24-h fluid intake measures at baseline and at the post-trial measurement
| Time point | Parameter | Control phase | Water protocol | ||
|---|---|---|---|---|---|
| No oral water access ( | Unsupervised oral water access ( | Supervised oral water access ( | Access conditions combined ( | ||
| Pre-trial fluid balance | Oral water intake (cc) | N/A | N/A | N/A | N/A |
| Other fluid intake (cc) | 1474 (1113–1836) | 1407 (729–2086) | 1495 (1167–1823) | 1460 (1180–1740) | |
| Total fluid intake (cc) | 1474 (1113–1836) | 1407 (729–2086) | 1495 (1167–1823) | 1460 (1180–1740) | |
| % of calculated requirements (%) | 63 (48–78) | 65 (30–100) | 68 (53–82) | 67 (53–81) | |
| Post-trial fluid balance | Oral water intake (cc) | N/A | 920 (181–1658) | 326 (43–609) | 563 (238–888) |
| Other fluid intake (cc) | 1427 (999–1855) | 1039 (682–1396) | 1423 (1009–1876) | 1281 (996–1566) | |
| Total fluid intake (cc) | 1427 (999–1855) | 1959 (1172–2745) | 1768 (1397–2140) | 1845 (1520–2169) | |
| % of calculated requirements (%) | 61 (44–79) | 90 (49–130) | 80 (64–96) | 84 (69–100) | |
Fluid: liquid consistency at room temperature. Total fluid intake: the combination of oral water intake plus other fluid intake (including oral thickened liquids and nonoral fluids)
Fig. 2Fluid intake in control and study groups
Sample-size calculations modeling the number of participants required in a prospective trial in order to detect an increase in the incidence of pneumonia as a negative outcome
| Stroke incidence figures | Range of probable aspirators (ACHPR) | Range of probable pneumonia incidence (ACHPR) | Threshold for detecting increased pneumonia occurrence (%) | No. of participants needed over 12 months (80% power) | |||
|---|---|---|---|---|---|---|---|
| Lower bound (43%) | Upper bound (54%) | Lower bound (16%) | Upper bound (20%) | ||||
| National | 745,781 | 320,686 | 402,722 | 119,325 | 149,850 | 45 | 238 |
| 42 | 592 | ||||||
| 40 | 1,628 | ||||||
| Local/institutional | 250 | 108 | 135 | 40 | 50 | 45 | 86 |
| 42 | 110 | ||||||
| 40 | 127 | ||||||
Based on reported national annual incidence rates for stroke (www.stroke.org) and pneumonia (ACHPR [14]) and hypothetical estimates of equivalent incidence at a local level